A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
Authors:
- Isabelle DesombereIDIsabelle Desombere
- Ahmed Atef MesalamAMAhmed Atef Mesalam
- Richard A. UrbanowiczRURichard A. Urbanowicz
- Freya Van HoutteFHFreya Van Houtte
- Lieven VerhoyeLVLieven Verhoye
- Zhen-Yong KeckZKZhen-Yong Keck
- Ali FarhoudiAFAli Farhoudi
- Koen VercauterenKVKoen Vercauteren
- Karin E. WeeningKWKarin E. Weening
- Thomas F. BaumertTBThomas F. Baumert
- Arvind H. PatelAPArvind H. Patel
- Steven K.H. FoungSFSteven K.H. Foung
Open Access
- 1 December 2017
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 148, 53-64
Abstract
No abstract availableKeywords
Funding Information
- Ghent University (01G01712)
- Belgian State (IUAP P7/47-HEPRO-2)
- European Union (HepaMab, HEPCAR, HEPCIR)
- Medical Research Council (MC_UU_12014/2)
- National Institute of Allergy and Infectious Diseases (U19-AI123862, R21-AI126582)
- NIH
This publication has 49 references indexed in Scilit:
- Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal AntibodiesJournal of Immunology Research, 2013
- Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in ChimpanzeesPLOS Pathogens, 2012
- Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a IsolatePLOS Pathogens, 2012
- Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive NeutralizationJournal of Virology, 2012
- Hepatitis C Patient-Derived Glycoproteins Exhibit Marked Differences in Susceptibility to Serum Neutralizing Antibodies: Genetic Subtype Defines Antigenic but Not Neutralization SerotypeJournal of Virology, 2011
- In Vivo Evaluation of the Cross-Genotype Neutralizing Activity of Polyclonal Antibodies Against Hepatitis C Virus ΔσHepatology, 2011
- Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantationJournal of Experimental Medicine, 2010
- Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs # †Hepatology, 2009
- Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasmaProceedings of the National Academy of Sciences, 2007
- Immunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV VirionsJournal of Virology, 2007